लोड हो रहा है...

Hepatitis B reactivation during or after direct acting antiviral therapy – implication for susceptible individuals

INTRODUCTION: The FDA issued a warning following 24 cases of HBV reactivation during DAA therapy for HCV, including individuals with inactive, occult and past HBV infection. Clinical presentations ranged from asymptomatic fluctuations in HBV DNA to fulminant hepatic failure, liver transplantation an...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Expert Opin Drug Saf
मुख्य लेखकों: Holmes, Jacinta A., Yu, Ming-Lung, Chung, Raymond T.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589072/
https://ncbi.nlm.nih.gov/pubmed/28471314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14740338.2017.1325869
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!